These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9655970)

  • 1. [Multiple actions of tacrolimus and cyclosporin A as specific inhibitors of calcineurin].
    Tamura K
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1118-30. PubMed ID: 9655970
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunosuppressive drugs and calcineurin].
    Masugi T; Otsuka K
    Tanpakushitsu Kakusan Koso; 1998 Sep; 43(12 Suppl):1739-43. PubMed ID: 9788176
    [No Abstract]   [Full Text] [Related]  

  • 3. [A second target of cyclosporin A and FK506].
    Matsuda S; Koyasu S
    Tanpakushitsu Kakusan Koso; 2000 Aug; 45(11):1823-31. PubMed ID: 10936966
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression.
    Timmerman LA; Clipstone NA; Ho SN; Northrop JP; Crabtree GR
    Nature; 1996 Oct; 383(6603):837-40. PubMed ID: 8893011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
    Koenen HJ; Michielsen EC; Verstappen J; Fasse E; Joosten I
    Transplantation; 2003 May; 75(9):1581-90. PubMed ID: 12792519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CA++/ calcineurin/NFAT signaling in endothelial activation and angiogenesis: effects od cyclosporin A ].
    Quesada AJ; Redondo JM
    Nefrologia; 2003; 23 Suppl 3():44-8. PubMed ID: 12901192
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcineurin.
    Hogan PG; Li H
    Curr Biol; 2005 Jun; 15(12):R442-3. PubMed ID: 15964258
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcineurin is a key signaling enzyme in T lymphocyte activation and the target of the immunosuppressive drugs cyclosporin A and FK506.
    Clipstone NA; Crabtree GR
    Ann N Y Acad Sci; 1993 Nov; 696():20-30. PubMed ID: 7509131
    [No Abstract]   [Full Text] [Related]  

  • 9. Manipulating immune responses with immunosuppressive agents that target NFAT.
    Kiani A; Rao A; Aramburu J
    Immunity; 2000 Apr; 12(4):359-72. PubMed ID: 10795734
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypertrophy of the heart: calcineurin-NFAT pathway may be a new therapeutic target].
    Zhang YJ; Dong LF; Wang YL
    Yao Xue Xue Bao; 2006 Oct; 41(10):913-6. PubMed ID: 17184105
    [No Abstract]   [Full Text] [Related]  

  • 11. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.
    Al-Daraji WI; Grant KR; Ryan K; Saxton A; Reynolds NJ
    J Invest Dermatol; 2002 May; 118(5):779-88. PubMed ID: 11982754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azodicarbonamide as a new T cell immunosuppressant: synergy with cyclosporin A.
    Tassignon J; Vandevelde M; Goldman M
    Clin Immunol; 2001 Jul; 100(1):24-30. PubMed ID: 11414742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function.
    Miroux C; Morales O; Ghazal K; Othman SB; de Launoit Y; Pancré V; Conti F; Delhem N
    Transplantation; 2012 Jul; 94(2):123-31. PubMed ID: 22743548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of calcineurin in the regulation of transcription factors].
    Omori N; Shibasaki F
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1047-54. PubMed ID: 9655962
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcineurin. Structure, function, and inhibition.
    Hemenway CS; Heitman J
    Cell Biochem Biophys; 1999; 30(1):115-51. PubMed ID: 10099825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRESK channel as a potential target to treat T-cell mediated immune dysfunction.
    Han J; Kang D
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1102-5. PubMed ID: 19852929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
    Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
    J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical involvement of IL-12 in IFN-gamma induction by calcineurin antagonists in activated human lymphocytes.
    Wittmann M; Killig C; Bruder M; Gutzmer R; Werfel T
    J Leukoc Biol; 2006 Jul; 80(1):75-86. PubMed ID: 16641133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of cyclosporin A and FK506.
    Bierer BE
    Prog Clin Biol Res; 1994; 390():203-23. PubMed ID: 7536944
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular and biological actions of cyclosporin A and FK506 on T cell development and function.
    Holländer GA; Bierer BE; Burakoff SJ
    Transfus Sci; 1994 Sep; 15(3):207-20. PubMed ID: 10155542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.